Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations

Cancer

Volumn 123, Issue 4, 2017, Pages 560-567

  Berger Richardson, David ^a,b   Swallow, Carol J ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

biopsy; extremity sarcoma; gastrointestinal stromal tumor (GIST); needle tract; retroperitoneal sarcoma; sarcoma; tumor seeding

Indexed keywords

DOXORUBICIN; IMATINIB;

BRACHYTHERAPY; CANCER GRADING; CANCER SURGERY; CHONDROSARCOMA; ENDOSCOPIC ULTRASONOGRAPHY; EWING SARCOMA; EXTERNAL BEAM RADIOTHERAPY; FINE NEEDLE ASPIRATION BIOPSY; GASTROINTESTINAL STROMAL TUMOR; HISTOLOGY; HUMAN; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; NEEDLE TRACT SEEDING; OSTEOSARCOMA; OUTCOME ASSESSMENT; PERCUTANEOUS BIOPSY; RETROPERITONEAL SARCOMA; REVIEW; RISK BENEFIT ANALYSIS; SARCOMA; SOFT TISSUE SARCOMA; TUMOR SEEDING; ADVERSE EFFECTS; COMPLICATION; PATHOLOGY; RISK ASSESSMENT;

BIOPSY, FINE-NEEDLE; HUMANS; NEOPLASM SEEDING; RISK ASSESSMENT; SARCOMA;

EID: 84997173344     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30370     Document Type: Review

References (71)

1. Hansen NM, Ye X, Grube BJ, Giuliano AE. Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg. 2004;139:634–639.
2. Singh HK, Kilpatrick SE, Silverman JF. Fine needle aspiration biopsy of soft tissue sarcomas: utility and diagnostic challenges. Adv Anat Pathol. 2004;11:24–37.
3. Tuttle R, Kane JM 3rd. Biopsy techniques for soft tissue and bowel sarcomas. J Surg Oncol. 2015;111:504–512.
4. Ray-Coquard I, Ranchere-Vince D, Thiesse P, et al. Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses. Eur J Cancer. 2003;39:2021–2025.
5. Welker JA, Henshaw RM, Jelinek J, Shmookler BM, Malawer MM. The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer. 2000;89:2677–2686.
6. Hidai H, Sakuramoto T, Miura T, Nakahashi M, Kikyo S. Needle tract seeding following puncture of retroperitoneal liposarcoma. Eur Urol. 1983;9:368–369.
7. Bergenfeldt M, Genell S, Lindholm K, Ekberg O, Aspelin P. Needle-tract seeding after percutaneous fine-needle biopsy of pancreatic carcinoma. Case report. Acta Chir Scand. 1988;154:77–79.
8. Ferrucci JT, Wittenberg J, Margolies MN, Carey RW. Malignant seeding of the tract after thin-needle aspiration biopsy. Radiology. 1979;130:345–346.
9. de Sio I, Castellano L, Calandra M, Del Vecchio-Blanco C. Subcutaneous needle-tract seeding after fine needle aspiration biopsy of pancreatic liver metastasis. Eur J Ultrasound. 2002;15:65–68.
10. Paquin SC, Gariepy G, Lepanto L, Bourdages R, Raymond G, Sahai AV. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc. 2005;61:610–611.
11. Mrzljak A, Kardum-Skelin I, Blaskovic D, Skegro D, Jadrijevic S, Colic-Cvrlje V. Needle tract seeding of hepatocellular carcinoma after liver transplantation [in Croatian]. Acta Med Croatica. 2011;65(suppl 1):189–195.
12. Takahashi N, Taniguchi T, Adachi M. A case of needle tract seeding of an intraductal papillary neoplasm of the bile duct (IPNB) after percutaneous biopsy. Eur J Dermatol. 2014;24:128–130.
13. Vergara V, Garripoli A, Marucci MM, Bonino F, Capussotti L. Colon cancer seeding after percutaneous fine needle aspiration of liver metastasis. J Hepatol. 1993;18:276–278.
14. Doi S, Yasuda I, Iwashita T, et al. Needle tract implantation on the esophageal wall after EUS-guided FNA of metastatic mediastinal lymphadenopathy. Gastrointest Endosc. 2008;67:988–990.
15. Pasieka JL, Thompson NW. Fine-needle aspiration biopsy causing peritoneal seeding of a carcinoid tumor. Arch Surg. 1992;127:1248–1251.
16. Chang DT, Sur H, Lozinskiy M, Wallace DM. Needle tract seeding following percutaneous biopsy of renal cell carcinoma. Korean J Urol. 2015;56:666–669.
17. Gibbons RP, Bush WH Jr, Burnett LL. Needle tract seeding following aspiration of renal cell carcinoma. J Urol. 1977;118:865–867.
18. Giorgadze T, Qureshi F, Aulicino M, Jacques SM. Retroperitoneal recurrence of a stage 1 renal cell carcinoma four years following core biopsy and fine needle aspiration: possible needle tract seeding. Diagn Cytopathol. 2013;41:470–472.
19. Kiser GC, Totonchy M, Barry JM. Needle tract seeding after percutaneous renal adenocarcinoma aspiration. J Urol. 1986;136:1292–1293.
20. Shenoy PD, Lakhkar BN, Ghosh MK, Patil UD. Cutaneous seeding of renal carcinoma by Chiba needle aspiration biopsy. Case report. Acta Radiol. 1991;32:50–52.
21. Yaycioglu O. Retroperitoneal recurrence of a stage 1 renal cell carcinoma 4 years following core biopsy and fine needle aspiration: possible needle tract seeding. Diagn Cytopathol. 2013;41:473.
22. Slywotzky C, Maya M. Needle tract seeding of transitional cell carcinoma following fine-needle aspiration of a renal mass. Abdom Imaging. 1994;19:174–176.
23. Moul JW, Bauer JJ, Srivastava S, et al. Perineal seeding of prostate cancer as the only evidence of clinical recurrence 14 years after needle biopsy and radical prostatectomy: molecular correlation. Urology. 1998;51:158–160.
24. Lee IS, Nguyen S, Shanberg AM. Needle tract seeding after percutaneous biopsy of Wilms tumor. J Urol. 1995;153(3 pt 2):1074–1076.
25. Auvert J, Abbou CC, Lavarenne V. Needle tract seeding following puncture of renal oncocytoma. Prog Clin Biol Res. 1982;100:597–598.
26. Gunter E, Grabenbauer G, Cidlinsky T, Heyder N, Hahn EG. Needle tract metastasis following sonographically guided puncture of a mesenteric lymph node metastasis in Pancoast's tumor [in German]. Dtsch Med Wochenschr. 1992;117:88–90.
27. Harter LP, Curtis JS, Ponto G, Craig PH. Malignant seeding of the needle track during stereotaxic core needle breast biopsy. Radiology. 1992;185:713–714.
28. Ishizuna K, Ota D, Okamoto J, et al. A case of mucinous carcinoma of the breast in which needle tract seeding was diagnosed by preoperative diagnostic imaging. Breast Cancer. 2011;18:324–327.
29. Polyzos SA, Anastasilakis AD. A systematic review of cases reporting needle tract seeding following thyroid fine needle biopsy. World J Surg. 2010;34:844–851.
30. Shah JN, Fraker D, Guerry D, Feldman M, Kochman ML. Melanoma seeding of an EUS-guided fine needle track. Gastrointest Endosc. 2004;59:923–924.
31. Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut. 2008;57:1592–1596.
32. Volanis D, Neal DE, Warren AY, Gnanapragasam VJ. Incidence of needle-tract seeding following prostate biopsy for suspected cancer: a review of the literature. BJU Int. 2015;115:698–704.
33. Cresswell AB, Welsh FK, Rees M. A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy? HPB (Oxford). 2009;11:533–540.
34. ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(suppl 3):iii102–iii112.
35. Chen MH, Wei Y, Yan K, et al. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol. 2006;17:671–683.
36. Espinoza S, Briggs P, Duret JS, Lapeyre M, de Baere T. Radiofrequency ablation of needle tract seeding in hepatocellular carcinoma. J Vasc Interv Radiol. 2005;16:743–746.
37. Yamanaka T, Shiraki K, Ito T, et al. Transcatheter arterial embolization and extrabeam radiation therapy for subcutaneous seeding of hepatocellular carcinoma by percutaneous ethanol injection. Hepatogastroenterology. 2002;49:1656–1658.
38. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;133:571–573.
39. Mao Y, Keller ET, Garfield DH, Shen K, Wang J. Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev. 2013;32:303–315.
40. Duda DG, Ancukiewicz M, Isakoff SJ, Krop IE, Jain RK. Seeds and soil: unraveling the role of local tumor stroma in distant metastasis. J Natl Cancer Inst. 2014;106. pii: dju187.
41. Hughes TM, Thomas JM. Sarcoma metastases due to iatrogenic implantation. Eur J Surg Oncol. 2000;26:50–52.
42. Walsh GL, Nesbitt JC. Tumor implants after thoracoscopic resection of a metastatic sarcoma. Ann Thorac Surg. 1995;59:215–216.
43. Sartorelli KH, Partrick D, Meagher DP Jr. Port-site recurrence after thoracoscopic resection of pulmonary metastasis owing to osteogenic sarcoma. J Pediatr Surg. 1996;31:1443–1444.
44. George S, Barysauskas C, Serrano C, et al. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer. 2014;120:3154–3158.
45. Parker WH, Kaunitz AM, Pritts EA, et al; Leiomyoma Morcellation Review Group. U.S. Food and Drug Administration's guidance regarding morcellation of leiomyomas: well-intentioned, but is it harmful for women? Obstet Gynecol. 2016;127:18–22.
46. US Food and Drug Administration. UPDATED Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication. Silver Spring, MD: US Food and Drug Administration; 2014.
47. Oliveira MP, Lima PM, da Silva HJ, de Mello RJ. Neoplasm seeding in biopsy tract of the musculoskeletal system. A systematic review. Acta Ortop Bras. 2014;22:106–110.
48. Oliveira MP, Lima PM, de Mello RJ. Tumor contamination in the biopsy path of primary malignant bone tumors. Rev Bras Ortop. 2015;47:631–637.
49. Mohana R, Faisham W, Zulmi W, Nawfar A, Effat O, Salzihan M. The incidence of malignant infiltration in the biopsy tract of osteosarcoma. Malays Orthop J. 2007;1:7–10.
50. Ribeiro MB, Oliveira CRGCMd, Filippi RZ, et al. Estudo histopatologico do trajeto de biopsia de tumores musculoesqueleticos malignos. Acta Ortop Bras. 2009;17:279–281.
51. Kaffenberger BH, Wakely PE Jr, Mayerson JL. Local recurrence rate of fine-needle aspiration biopsy in primary high-grade sarcomas. J Surg Oncol. 2010;101:618–621.
52. Saghieh S, Masrouha KZ, Musallam KM, et al. The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas. Iowa Orthop J. 2010;30:80–83.
53. Davies NM, Livesley PJ, Cannon SR. Recurrence of an osteosarcoma in a needle biopsy track. J Bone Joint Surg Br. 1993;75:977–978.
54. Schwartz HS, Spengler DM. Needle tract recurrences after closed biopsy for sarcoma: three cases and review of the literature. Ann Surg Oncol. 1997;4:228–236.
55. Zoccali C, Prencipe U, Erba F, Vidiri A, Di Filippo F. Biopsy can determinate tumoral track contamination: a case report of chondrosarcoma. Eur J Radiol Extra. 2009;72:e79–e81.
56. Binitie O, Tejiram S, Conway S, Cheong D, Temple HT, Letson GD. Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract. Clin Orthop Relat Res. 2013;471:891–898.
57. Gronchi A, Lo Vullo S, Colombo C, et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg. 2010;251:506–511.
58. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679–1689.
59. Espinosa LA, Jamadar DA, Jacobson JA, et al. CT-guided biopsy of bone: a radiologist's perspective. AJR Am J Roentgenol. 2008;190:W283–W289.
60. UyBico SJ, Motamedi K, Omura MC, et al. Relevance of compartmental anatomic guidelines for biopsy of musculoskeletal tumors: retrospective review of 363 biopsies over a 6-year period. J Vasc Interv Radiol. 2012;23:511–518, 518.e1-2.
61. Liu PT, Valadez SD, Chivers FS, Roberts CC, Beauchamp CP. Anatomically based guidelines for core needle biopsy of bone tumors: implications for limb-sparing surgery. Radiographics. 2007;27:189–205.
62. Anderson MW, Temple HT, Dussault RG, Kaplan PA. Compartmental anatomy: relevance to staging and biopsy of musculoskeletal tumors. AJR Am J Roentgenol. 1999;173:1663–1671.
63. Andtbacka RH, Ng CS, Scaife CL, et al. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol. 2007;14:14–24.
64. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–58.
65. Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010;8(suppl 2):S1–S41; quiz S42-S44.
66. Jenssen C, Barreiros AP, Will U, Burmester E, Schmidtmann I, Eckardt AJ. German survey on EUS-guided diagnosis and management of gastrointestinal stromal tumors (GISTs)-evidence or “gut-feeling”? Ultraschall Med. 2015;36:494–500.
67. Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc. 2003;58:690–695.
68. Jenssen C, Alvarez-Sanchez MV, Napoleon B, Faiss S. Diagnostic endoscopic ultrasonography: assessment of safety and prevention of complications. World J Gastroenterol. 2012;18:4659–4676.
69. Eriksson M, Reichardt P, Sundby Hall K, et al. Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour-does it increase the risk for tumour cell seeding and recurrence? Eur J Cancer. 2016;59:128–133.
70. Wilkinson MJ, Martin JL, Khan AA, Hayes AJ, Thomas JM, Strauss DC. Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival. Ann Surg Oncol. 2015;22:853–858.
71. Hwang SY, Warrier S, Thompson S, Davidson T, Yang JL, Crowe P. Safety and accuracy of core biopsy in retroperitoneal sarcomas. Asia Pac J Clin Oncol. 2016;12:e174–e178.